Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

Abstract

OBJECTIVE To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort. RESEARCH DESIGN AND METHODS We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation. RESULTS Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04–1.42), C. bolteae (HR 1.20; 95% CI 1.04–1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01–1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01–1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02–1.38) and cluster 5 (HR 1.18; 95% CI 1.02–1.36), mostly consisted of these same species. CONCLUSIONS We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.

Intestinal Microbes in Patients With Schizophrenia Undergoing Short-Term Treatment: Core Species Identification Based on Co-Occurrence Networks and Regression Analysis

“…Previous studies have shown that Ruminococcus spp. is significantly associated with Crohn's disease, IBD, and type 2 diabetes (Hall et al, 2017;Baumgartner et al, 2021;Ruuskanen et al, 2022).…”

Effect of Phorate on the Development of Hyperglycaemia in Mouse and Resistance Genes in Intestinal Microbiota

“…We found that efflux pumps were the main mechanism of drug resistance in Firmicutes , Proteobacteria , Bacteroidetes , Verrucomicrobia , Synergistetes , Spirochaetes , and Actinobacteria . Notably, Firmicutes , Proteobacteria , and Bacteroidetes have been found to be dominant in the microbiota of mice and humans [ 27 ]. Therefore, we suspect that phorate causes hyperglycaemia in mice primarily by causing the dominant bacteria in the intestine to produce efflux pumps.…”

Evaluating the clinical relevance of the enterotypes in the Estonian microbiome cohort

“…The implications on health and disease have particularly fed the growing interest in the microbiome field with the possibility of using the microbiome profile as a novel tool for disease diagnostics and microbiome-informed personalized therapeutics in mind ( di Pierro, 2021 ; Zeevi et al, 2015 ). Moreover, recent studies show the potential of using the microbiome as a prognostic marker for disease progression, leading to personalized risk estimation ( Aasmets et al, 2021 ; Liu et al, 2022 ; Ruuskanen et al, 2022 ; H. Wang et al, 2022 ). Taken together, the microbiome carries relevant information about one’s health which can be exploited for the benefit of public well-being.…”